The Effect of the Anticholinergic Burden Following Elective Coronary Artery Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 1, 2024

Study Completion Date

December 30, 2024

Conditions

MortalityPostoperative Complications

Interventions

DRUG

reducing anticholinergic burden

In the intraoperative and postoperative periods instead of drugs with high anticholinergic burden; drugs with low burden will be preferred.

Trial Locations (1)

Seda Kurtbeyoğlu, Çankaya

All Listed Sponsors

lead

Ankara City Hospital Bilkent

OTHER

NCT06349057 - The Effect of the Anticholinergic Burden Following Elective Coronary Artery Surgery | Biotech Hunter | Biotech Hunter